Page 264 of articles about markets-economics in Swine news

EU - Commission adopts regulation for import controls on certain food and feed of non-animal origin

24-Jul-2009
The Commission has adopted today a regulation to allow known or emerging risks in feed and food of non-animal origin to be countered more effectively. This regulation requires Member States to step up controls on certain imports of feed and food of non-animal origin. Member States are required to designate points of entry, which comply with the minimum requirements laid down in the regulation (logistics, staff, access to appropriate laboratory capacity, etc) through which consignments must enter the territory of the EU. The enhanced control mechanism means systematic (100%) checks on documents accompanying the consignments, as well as physical checks, including laboratory analysis, at a frequency related to the risk identified. For the first time the regulation also lays down the list of products that are subject to these stepped-up controls. The imported products listed are products which merit an increased level of attention and control at borders on the basis of information from various sources (RASFF notifications, reports from the Food and Veterinary Office (FVO), from Member States and from third countries).

Italy - Pork production increase

24-Jul-2009
Poultry and pork production will grow by 37.64% and 8.88%, respectively 2009-2013, although beef production will fall by 1.24%. The growth in poultry and pork production will be partly driven by domestic demand and should also lead to improved balances of trade.

China - Hog production increases

22-Jul-2009
The country’s total live pig production for the first half of this year could reach 390.5 million, a 6% increase over the same period of last year.

EU - Mergers: Commission clears Pfizer's proposed acquisition of Wyeth, subject to conditions

21-Jul-2009
The European Commission has approved under the EU Merger Regulation the proposed acquisition of the US pharmaceutical and health care products company Wyeth by the US global pharmaceutical company Pfizer. The approval is conditional upon Pfizer's commitment to divest several types of animal health vaccines, pharmaceuticals and medicinal feed additives in the European Economic Area (EEA) or in specific Member States. The Commission had concerns that the transaction, as originally notified, would have raised competition issues in the field of animal health products on a number of national markets. In the light of the commitments offered by Pfizer, the Commission has now concluded that the proposed transaction would not significantly impede effective competition in the EEA or any substantial part of it.